1 Min Read
March 6 (Reuters) - Vertex Pharmaceuticals Inc:
* Vertex to acquire CTP-656 from Concert Pharmaceuticals for the treatment of cystic fibrosis Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.